While AR signaling remains the primary factor driving prostate cancer, even in the progression to CRPC44, our results demonstrate that expression of CXCR7 is essential for prostate cancer cell survival and a critical factor during the transition to castration resistance. Here, ACKR3 is linked to prostate carcinoma.